{"blog": [], "keywords": [{"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "1", "is_major": "Y"}, {"value": "Amarin Corp PLC", "name": "organizations", "rank": "2", "is_major": "Y"}, {"value": "Food and Drug Administration", "name": "organizations", "rank": "3", "is_major": "Y"}, {"value": "Freedom of Speech and Expression", "name": "subject", "rank": "4", "is_major": "Y"}, {"value": "Labeling and Labels (Product)", "name": "subject", "rank": "5", "is_major": "N"}, {"value": "Suits and Litigation (Civil)", "name": "subject", "rank": "6", "is_major": "N"}], "web_url": "http://www.nytimes.com/2015/05/08/business/drugmaker-sues-fda-over-right-to-discuss-off-label-uses.html", "document_type": "article", "byline": {"person": [{"lastname": "THOMAS", "firstname": "Katie", "role": "reported", "organization": "", "rank": 1}], "original": "By KATIE THOMAS"}, "type_of_material": "News", "multimedia": [], "section_name": "Business Day", "word_count": "944", "source": "The New York Times", "subsection_name": null, "lead_paragraph": "Amarin Pharma says it has a constitutional right to share information on unapproved uses of its products, a practice the government frowns on.", "pub_date": "2015-05-08T00:00:00Z", "news_desk": "Business", "headline": {"print_headline": "Drugmaker Sues F.D.A. to Discuss Off-Label Uses", "main": "Drugmaker Sues F.D.A. Over Right to Discuss Off-Label Uses"}, "print_page": "3", "snippet": "Amarin Pharma says it has a constitutional right to share information on unapproved uses of its products, a practice the government frowns on.", "_id": "554bd09a38f0d87a4d2b58be", "slideshow_credits": null, "abstract": "Amarin Pharma brings novel free-speech suit against Food and Drug Administration, saying agency has no constitutional grounds to bar pharmaceutical companies from discussing off-label medication usage with doctors; argues FDA has no right to bar transmission of accurate information, but critics say promotion of off-label use dangerously sidesteps agency's authority."}